Celine Dubath
Overview
Explore the profile of Celine Dubath including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
22
Citations
86
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Dubath C, Porcu E, Delacretaz A, Grosu C, Laaboub N, Piras M, et al.
Clin Epigenetics
. 2024 Feb;
16(1):36.
PMID: 38419113
Background: Metabolic side effects of psychotropic medications are a major drawback to patients' successful treatment. Using an epigenome-wide approach, we aimed to investigate DNA methylation changes occurring secondary to psychotropic...
2.
Grandjean C, Vandenberghe F, Dubath C, Sibailly G, Ansermot N, Crettol Wavre S, et al.
Rev Med Suisse
. 2023 Sep;
19(842):1707-1712.
PMID: 37728265
Antipsychotics are known to produce frequent and/or potentially serious adverse effects, including neurological, cardiovascular, metabolic and endocrine effects. The side-effects of antipsychotics vary according to their affinity for different central...
3.
Sjaarda J, Delacretaz A, Dubath C, Laaboub N, Piras M, Grosu C, et al.
Mol Psychiatry
. 2023 May;
28(6):2320-2327.
PMID: 37173452
Patients suffering from mental disorders are at high risk of developing cardiovascular diseases, leading to a reduction in life expectancy. Genetic variants can display greater influence on cardiometabolic features in...
4.
Buso G, Favre L, Vionnet N, Gonzalez-Rodriguez E, Hans D, Puder J, et al.
Obes Facts
. 2022 Oct;
15(6):762-773.
PMID: 36310013
Introduction: Lipedema is a poorly known condition. Diagnosis is based almost exclusively on clinical criteria, which may be subjective and not always reliable. This study aimed to investigate regional body...
5.
Perry B, Vandenberghe F, Garrido-Torres N, Osimo E, Piras M, Vazquez-Bourgon J, et al.
Lancet Reg Health Eur
. 2022 Aug;
22:100493.
PMID: 36039146
Background: Cardiometabolic dysfunction is common in young people with psychosis. Recently, the Psychosis Metabolic Risk Calculator (PsyMetRiC) was developed and externally validated in the UK, predicting up-to six-year risk of...
6.
Laaboub N, Dubath C, Ranjbar S, Sibailly G, Grosu C, Piras M, et al.
BMC Psychiatry
. 2022 Jul;
22(1):457.
PMID: 35804331
No abstract available.
7.
Laaboub N, Dubath C, Ranjbar S, Sibailly G, Grosu C, Piras M, et al.
BMC Psychiatry
. 2022 May;
22(1):342.
PMID: 35581641
Study Objectives: Insomnia disorders as well as cardiometabolic disorders are highly prevalent in the psychiatric population compared to the general population. We aimed to investigate their association and evolution over...
8.
Piras M, Dubath C, Gholam M, Laaboub N, Grosu C, Gamma F, et al.
J Clin Psychiatry
. 2022 May;
83(4).
PMID: 35551499
Atypical antipsychotics can induce metabolic side effects, but whether they are dose-dependent remains unclear. To assess the effect of risperidone and/or paliperidone dosing on weight gain and blood lipids, glucose,...
9.
Schoretsanitis G, Dubath C, Grosu C, Piras M, Laaboub N, Ranjbar S, et al.
Basic Clin Pharmacol Toxicol
. 2022 Feb;
130(4):531-541.
PMID: 35150056
Metabolic abnormalities have been associated with olanzapine treatment. We assessed if olanzapine has dose-dependent effects on metabolic parameters with changes for weight, blood pressure, lipid and glucose profiles being modelled...
10.
Laaboub N, Gholam M, Sibailly G, Sjaarda J, Delacretaz A, Dubath C, et al.
Front Psychiatry
. 2022 Jan;
12:756403.
PMID: 34987426
We first sought to examine the relationship between plasma levels of methylxanthines (caffeine and its metabolites) and sleep disorders, and secondarily between polygenic risk scores (PRS) of caffeine consumption or...